Skip to main content
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. — Investor Relations & Filings

Ticker · LEXX ISIN · US52886N4060 US Professional, scientific and technical activities
Open in API
Filings indexed 1,010 across all filing types
Latest filing 2026-04-13 Interim / Quarterly Rep…
Country US United States of America
Listing US LEXX

About Lexaria Bioscience Corp.

https://www.lexariabioscience.com/

Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of its patented drug delivery platform, DehydraTECH™. This technology is designed to improve the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral administration. DehydraTECH™ enhances the bioavailability of APIs, which can enable faster absorption, increased efficacy, and the potential for reduced drug dosages. The company operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with numerous patents granted globally for its platform technology.

Recent filings

Filing Released Lang Actions
10-Q - Lexaria Bioscience Corp. (0001348362) (Filer)
Interim / Quarterly Report Q2 2026
2026-04-13 English
4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
Director's Dealing
2026-03-18 English
8-K Filing
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 4, 2026, by Lexaria Bioscience Corp. The key content is a notice from Nasdaq regarding the company's non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. It details the deficiency notice, the compliance period, potential consequences including delisting, and the company's intention to monitor and address the issue. This is a regulatory announcement about a potential delisting event, not a financial report or earnings release. The document specifically addresses a delisting risk and process, which fits the definition of a Delisting Announcement (DLST). The document length is over 5,000 characters and contains substantive information about the delisting notice, not just a brief announcement or reference to another report. Therefore, the correct classification is DLST with high confidence.
2026-02-06 English
S-8 Filing
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It includes detailed information about the equity incentive plan, shares reserved for issuance, and a reoffer prospectus for resale of shares by selling stockholders. The document is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration and offering. It is a registration statement under the Securities Act of 1933, specifically Form S-8, which is a type of regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement of a report, so it is not RPA. It is not a certification or attestation, so not RNS for certification reasons, but rather a regulatory filing. Confidence is high due to clear identification of the form and content.
2026-01-28 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 27, 2026, reporting the submission of matters to a vote of security holders at the company's annual shareholder meeting. It includes detailed voting results for director elections, auditor appointment, and ratification of directors' actions. The document explicitly states it is reporting the voting results from the annual meeting. It is not the proxy statement itself, nor is it an announcement of a report publication. The content matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4247 characters, which is sufficient to contain detailed voting results rather than just an announcement. Therefore, the correct classification is DVA with high confidence.
2026-01-28 English
25-NSE Filing
Delisting Announcement
2026-01-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.